Table 6. Logistic regression analyses.
| Adjusted odds ratio* (95% CI) | Any retinopathyR1, R2 or R3(n = 20,344) | Any proliferative diabetic retinopathyR2 or R3(n = 2,195) | CSMOM1P1(n = 2,446) | STDRR2 or R3 or M1P1(n = 3,426) |
| Age (per year age) | 1.007 (1.006, 1.008) | 1.005 (1.002, 1.009) | 1.019 (1.016,1.022) | 1.012 (1.099,1.015) |
| Men | 1 | 1 | 1 | 1 |
| Women | 0.93 (0.90,0.97) | 0.77 (0.71,0.84) | 0.91 (0.84,0.99) | 0.84 (0.78,0.90) |
| West Yorkshire | 1 | 1 | 1 | 1 |
| South East London | 0.91 (0.87, 0.94) | 0.69 (0.63, 0.77) | 1.79 (1.61, 1.99) | 1.04 (0.96,1.13) |
| Type I diabetes | 1 | 1 | 1 | 1 |
| Type 2 diabetes | 0.47 (0.43, 0.51) | 0.32 (0.27, 0.37) | 0.42 (0.35, 0.49) | 0.35 (0.31, 0.40) |
| White Europeans | 1 | 1 | 1 | 1 |
| African/Afro-Caribbeans | 1.79 (1.70, 1.89) | 1.61 (1.42, 1.82) | 2.12 (1.91, 2.35) | 1.99 (1.81,2.18) |
| South Asians | 1.10 (1.02, 1.18) | 1.52 (1.31, 1.77) | 1.98 (1.71, 2.30) | 1.82 (1.61, 2.06) |
| Other | 0.75 (0.70, 0.80) | 0.59 (0.48, 0.72) | 0.68 (0.57, 0.81) | 0.68 (0.58, 0.79) |
*
Adjusted for all factors on the table.
CSMO- clinically significant macular oedema; R1- Mild to moderate non-proliferative diabetic retinopathy; R2- Severe non-proliferative diabetic retinopathy; R3- Proliferative diabetic retinopathy; M1P1- laser treated diabetic maculopathy; STDR-sight threatening diabetic retinopathy.